Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

Yasushi Fukushima,1 Yuji Nakatani,2 Yumiko Ide,3 Hisakuni Sekino,4 Earl St Rose,5 Shahid Siddiqui,6 Andrea Maes,5 Colin Reisner5,6 1Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan; 2Department of Internal Medicine, Nakatani Hospital, Hyogo, Japan; 3Department of Internal Medicine, Toky...

Full description

Bibliographic Details
Main Authors: Fukushima Y, Nakatani Y, Ide Y, Sekino H, St Rose E, Siddiqui S, Maes A, Reisner C
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:International Journal of COPD
Subjects:
bronchodilator agents
dose-response relationship
forced expiratory volume
metered dose inhalers
chronic obstructive pulmonary disease.
Online Access:https://www.dovepress.com/randomized-double-blind-placebo-controlled-trial-to-assess-the-efficac-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/randomized-double-blind-placebo-controlled-trial-to-assess-the-efficac-peer-reviewed-article-COPD

Similar Items